236 related articles for article (PubMed ID: 6809316)
21. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma.
Xue H; Wang H; Kong L; Zhou H
Chin Med J (Engl); 1998 Aug; 111(8):751-3. PubMed ID: 11245034
[TBL] [Abstract][Full Text] [Related]
22. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption.
Barth RF; Yang W; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH; Soloway AH
Cancer Res; 1997 Mar; 57(6):1129-36. PubMed ID: 9067283
[TBL] [Abstract][Full Text] [Related]
23. Graded reversible opening of the rat blood-brain barrier by intracarotid infusion of sodium caprate.
Preston E; Slinn J; Vinokourov I; Stanimirovic D
J Neurosci Methods; 2008 Mar; 168(2):443-9. PubMed ID: 18155299
[TBL] [Abstract][Full Text] [Related]
24. Effect of osmotic blood-brain barrier disruption on methotrexate pharmacokinetics in the dog.
Neuwelt EA; Frenkel EP; Rapoport S; Barnett P
Neurosurgery; 1980 Jul; 7(1):36-43. PubMed ID: 6774280
[TBL] [Abstract][Full Text] [Related]
25. [Hemodynamic effects of an osmotic bolus for the reversible opening of the blood-brain barrier].
Hiesmayr M; Dirnberger H; Aloy A; Heimberger K; Horaczek A; Brandstätter B; Zimpfer M
Schweiz Med Wochenschr; 1987 Mar; 117(12):450-4. PubMed ID: 3107120
[TBL] [Abstract][Full Text] [Related]
26. Seizure-promoting effect of blood-brain barrier disruption.
Marchi N; Angelov L; Masaryk T; Fazio V; Granata T; Hernandez N; Hallene K; Diglaw T; Franic L; Najm I; Janigro D
Epilepsia; 2007 Apr; 48(4):732-42. PubMed ID: 17319915
[TBL] [Abstract][Full Text] [Related]
27. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
28. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Goldstein DA; Tessler HH
Am J Ophthalmol; 2007 Dec; 144(6):976; author reply 976. PubMed ID: 18036877
[No Abstract] [Full Text] [Related]
29. Intra-arterial chemotherapy following blood-brain barrier disruption in a patient with malignant glioma.
Hill SA; Neuwelt EA
J Neurosurg Nurs; 1982 Apr; 14(2):94-7. PubMed ID: 6811704
[No Abstract] [Full Text] [Related]
30. Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.
Chen CH; Toung TJ; Sapirstein A; Bhardwaj A
J Cereb Blood Flow Metab; 2006 Jul; 26(7):951-8. PubMed ID: 16306935
[TBL] [Abstract][Full Text] [Related]
31. Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
Galor A; Ference SJ; Singh AD; Lee MS; Stevens GH; Perez VL; Peereboom DM
Am J Ophthalmol; 2007 Jul; 144(1):45-49. PubMed ID: 17601426
[TBL] [Abstract][Full Text] [Related]
32. Is intra-arterial chemotherapy useful in high-grade gliomas?
Basso U; Lonardi S; Brandes AA
Expert Rev Anticancer Ther; 2002 Oct; 2(5):507-19. PubMed ID: 12382519
[TBL] [Abstract][Full Text] [Related]
33. Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?
Kemper EM; Boogerd W; Thuis I; Beijnen JH; van Tellingen O
Cancer Treat Rev; 2004 Aug; 30(5):415-23. PubMed ID: 15245774
[TBL] [Abstract][Full Text] [Related]
34. Synergistic effect of cold mannitol and Na(+)/Ca(2+) exchange blocker on blood-brain barrier opening.
Ikeda M; Bhattacharjee AK; Kondoh T; Nagashima T; Tamaki N
Biochem Biophys Res Commun; 2002 Mar; 291(3):669-74. PubMed ID: 11855842
[TBL] [Abstract][Full Text] [Related]
35. Monitoring of methotrexate delivery in patients with malignant brain tumors after osmotic blood-brain barrier disruption.
Neuwelt EA; Diehl JT; Vu LH; Hill SA; Michael AJ; Frenkel EP
Ann Intern Med; 1981 Apr; 94(4 pt 1):449-54. PubMed ID: 6782926
[TBL] [Abstract][Full Text] [Related]
36. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
Brown RC; Egleton RD; Davis TP
Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
[TBL] [Abstract][Full Text] [Related]
37. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies.
Cosolo WC; Martinello P; Louis WJ; Christophidis N
Am J Physiol; 1989 Feb; 256(2 Pt 2):R443-7. PubMed ID: 2492773
[TBL] [Abstract][Full Text] [Related]
38. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits.
Wang M; Etu J; Joshi S
J Neurosurg Anesthesiol; 2007 Oct; 19(4):249-56. PubMed ID: 17893577
[TBL] [Abstract][Full Text] [Related]
39. Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
Zünkeler B; Carson RE; Olson J; Blasberg RG; Girton M; Bacher J; Herscovitch P; Oldfield EH
J Neurosurg; 1996 Mar; 84(3):494-502. PubMed ID: 8609564
[TBL] [Abstract][Full Text] [Related]
40. [The blood-brain barrier: implications for chemotherapy in brain tumors].
Boaziz C; Breau JL; Morère JF; Israël L
Pathol Biol (Paris); 1991 Oct; 39(8):789-95. PubMed ID: 1762838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
